Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;

Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency Luis Ignacio González-Granado; Andrea Martín-Nalda; Laia Alsina; Olaf Neth; Manuel Santamaría; Pere Soler-Palacín;

Impact on neonatal morbidity of moderate to severe early foetal growth restriction defined by doppler criteria: multicentre study Jesús Alberto Fuentes Carballal; Marcelino Pumarada Prieto; Pilar Adelaida Crespo Suárez; José Luaces González; Isabel López Conde; Rosaura Picans Leis; Alicia Sardina Ríos; Cristina Durán Fernández-Feijoo; Alejandro Avila-Alvarez;